FI894423L - Kompositioner och foerfarande foer foerhindring av befruktning och kontroll av broestcancer. - Google Patents

Kompositioner och foerfarande foer foerhindring av befruktning och kontroll av broestcancer. Download PDF

Info

Publication number
FI894423L
FI894423L FI894423A FI894423A FI894423L FI 894423 L FI894423 L FI 894423L FI 894423 A FI894423 A FI 894423A FI 894423 A FI894423 A FI 894423A FI 894423 L FI894423 L FI 894423L
Authority
FI
Finland
Prior art keywords
och
foerhindring
broestcancer
befruktning
kontroll
Prior art date
Application number
FI894423A
Other languages
English (en)
Finnish (fi)
Other versions
FI894423A0 (fi
FI894423A7 (fi
Inventor
Michael Cohen
Original Assignee
Applied Med Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Med Res filed Critical Applied Med Res
Publication of FI894423A0 publication Critical patent/FI894423A0/fi
Publication of FI894423A7 publication Critical patent/FI894423A7/fi
Publication of FI894423L publication Critical patent/FI894423L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Seeds, Soups, And Other Foods (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
FI894423A 1987-03-23 1988-03-22 Kompositioner och foerfarande foer foerhindring av befruktning och kontroll av broestcancer. FI894423L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/029,229 US4855305A (en) 1987-03-23 1987-03-23 Compositions and methods of effecting contraception utilizing melatonin
PCT/US1988/000971 WO1988007370A1 (en) 1987-03-23 1988-03-22 Compositions and methods of effecting contraception and control of breast cancer

Publications (3)

Publication Number Publication Date
FI894423A0 FI894423A0 (fi) 1989-09-19
FI894423A7 FI894423A7 (fi) 1989-09-19
FI894423L true FI894423L (fi) 1989-09-19

Family

ID=21847942

Family Applications (1)

Application Number Title Priority Date Filing Date
FI894423A FI894423L (fi) 1987-03-23 1988-03-22 Kompositioner och foerfarande foer foerhindring av befruktning och kontroll av broestcancer.

Country Status (26)

Country Link
US (1) US4855305A (fa)
EP (1) EP0354921B1 (fa)
JP (2) JP2965160B2 (fa)
KR (1) KR890700349A (fa)
CN (1) CN1041383C (fa)
AT (1) ATE143807T1 (fa)
AU (3) AU628784B2 (fa)
BG (1) BG51075A1 (fa)
BR (1) BR8807426A (fa)
CA (1) CA1322527C (fa)
DD (1) DD269557A5 (fa)
DE (1) DE3855606T2 (fa)
EG (1) EG18583A (fa)
ES (1) ES2009251A6 (fa)
FI (1) FI894423L (fa)
GR (1) GR1002146B (fa)
HU (1) HU208487B (fa)
IL (1) IL85814A (fa)
IN (1) IN166946B (fa)
NZ (1) NZ223989A (fa)
OA (1) OA09134A (fa)
PH (1) PH26709A (fa)
PT (1) PT87053B (fa)
RU (1) RU2114621C1 (fa)
WO (1) WO1988007370A1 (fa)
ZA (1) ZA882079B (fa)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1001395B (el) * 1987-03-23 1993-10-29 Michael Cohen Συν?έσεις και μέ?οδοι προς πραγματοποίηση αντισύλληψης.
EP0300630A3 (en) * 1987-07-03 1990-03-28 Schering Agrochemicals Limited Melatonin for regulating animal reproduction
EP0305194A3 (en) * 1987-08-28 1990-03-28 Schering Agrochemicals Limited Veterinary composition
US4945103A (en) * 1989-01-17 1990-07-31 Michael Cohen Method of treating pre-menstrual syndrome
IN170311B (fa) * 1989-01-17 1992-03-14 Cohen Michael
GR900100024A (el) * 1989-01-17 1991-06-07 Amr Int Μέθοδος θεραπείας του προεμμηνορροϊκού συνδρόμου.
NZ233697A (en) * 1989-05-17 1996-12-20 Applied Med Res Ltd Contraceptive composition comprising a melatonin analogue and a progestogen and/or an estrogen
AU644367B2 (en) * 1989-05-17 1993-12-09 Applied Medical Research Ltd Use of melatonin derivatives for effecting contraception
IT1243193B (it) * 1990-08-10 1994-05-24 Medea Res Srl Composizioni farmaceutiche orali a base di melatonina
DK0483077T3 (da) * 1990-09-28 1996-04-15 I F L O S A S Di Giorgio E Ald Fremgangsmåde til syntese af et kontraceptivt og menstruationscyklus-kontrollerende lægemiddel med onkostatiske, antikinetosiske, præventive og terapeutiske egenskaber til behandling af brysttumorer og melanomer
ATE181670T1 (de) * 1991-05-09 1999-07-15 Neurim Pharma 1991 Melatonin enthaltende arzneimittel
PT100973A (pt) * 1991-10-18 1994-06-30 Alza Corp Dispositivo e composicoes farmaceuticas para a administracao de melatonina por via transdermica
US5196435A (en) * 1991-11-21 1993-03-23 Eli Lilly And Company Melatonin derivatives and combinations with antiestrogen compounds for treating mammalian breast carcinoma
ES2090861T3 (es) * 1992-04-07 1996-10-16 Neurim Pharma 1991 Utilizacion de melatonina para la preparacion de un medicamento para el tratamiento de la hiperplasia de prostata benigna.
US5792785A (en) * 1995-11-24 1998-08-11 Equitech Laboratories, Inc. Method for enhancing pregnancy success in an animal
US6403631B1 (en) 1995-11-24 2002-06-11 Equitech Laboratories, Inc. Method and compositions for enhancing pregnancy success in an animal
US6028064A (en) * 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6620836B1 (en) * 1997-01-22 2003-09-16 Jay Patrick Antiarrhythmic and tranquilizer composition and treatment
DE19739916C2 (de) * 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
NZ504351A (en) 1997-11-14 2002-10-25 Akzo Nobel Nv Contraceptive kit comprising progestogen and anti-progestogen and use in treating bleeding induced by a progestogen-only contraceptive regimen
US6133453A (en) * 1998-05-15 2000-10-17 Pharm-Eco Laboratories, Inc. Method for making substituted indoles
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US6660726B2 (en) 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US20050113351A1 (en) * 2000-03-21 2005-05-26 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20040176336A1 (en) * 2000-03-21 2004-09-09 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20030139384A1 (en) * 2000-08-30 2003-07-24 Dudley Robert E. Method for treating erectile dysfunction and increasing libido in men
EP1315502B1 (en) * 2000-08-30 2010-03-17 Unimed Pharmaceuticals, LLC Method for treating erectile dysfunction and increasing libido in men
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
AU2003230644A1 (en) * 2002-03-14 2003-09-29 Ercole L. Cavalieri A unifying mechanism and methods to prevent cancer and neurodegenerative diseases
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
JP2006522833A (ja) * 2003-04-11 2006-10-05 バー・ラボラトリーズ，インコーポレイテッド エストロゲンおよびプロゲスチンの投与法
US20070027076A1 (en) 2003-09-09 2007-02-01 Fumapham Ag Use of fumaric acid derivatives for treating cardiac insufficiency, and asthma
MXPA06013418A (es) * 2004-05-26 2007-01-23 Wyeth Corp Composiciones y metodos para el tratamiento del trastorno disforico premenstrual.
EP2965751A1 (en) 2004-10-08 2016-01-13 Forward Pharma A/S Controlled release pharmaceutical compositions comprising a fumaric acid ester
EP3456329B1 (en) 2005-10-12 2024-12-04 Besins Healthcare Luxembourg SARL Improved testosterone gel and method of use
EP2068695A2 (en) * 2006-09-13 2009-06-17 Koninklijke Philips Electronics N.V. Device for automatic adjustment of the dose of melatonin and/or delivery of melatonin
DE13169139T1 (de) 2007-02-08 2022-07-14 Biogen MA Inc. Zusammensetzungen und deren Verwendung zur Behandlung von Multipler Sklerose
DE102008036825A1 (de) * 2008-08-05 2010-02-11 Aicuris Gmbh & Co. Kg Schwangerschaftsvermeidung durch Gestagene
FR2937862B1 (fr) * 2008-11-03 2010-11-19 Mohammed Ridha Chakroun Kit contraceptif
EP3124023B1 (en) * 2014-03-27 2023-08-30 Servicio Andaluz De Salud Durable preparation of an injectable of melatonin exhibiting long-term stability
RU2617518C2 (ru) * 2015-07-01 2017-04-25 Общество с ограниченной ответственностью "Научно-внедренческий центр Агроветзащита" Способ регулирования полового поведения и контрацепции самок млекопитающих
RU2616252C2 (ru) * 2015-08-04 2017-04-13 Общество с ограниченной ответственностью "Научно-внедренческий центр Агроветзащита" Способ регулирования полового поведения самцов млекопитающих

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087444A (en) * 1976-09-08 1978-05-02 Eli Lilly And Company Amides as ovulation inhibitors
EP0004770B1 (en) * 1978-04-11 1984-06-13 Efamol Limited Pharmaceutical and dietary composition comprising gamma-linolenic acids
US4425339A (en) * 1981-04-09 1984-01-10 Syntex (U.S.A.) Inc. Treatment of menopausal symptoms
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4628051A (en) * 1983-09-26 1986-12-09 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4614807A (en) * 1984-10-04 1986-09-30 Eli Lilly And Company 6,7-dihalomelatonins
ATE77230T1 (de) * 1985-03-04 1992-07-15 Cell Eng Ag Melatoninhaltige mittel sowie deren verwendungen.
US4746674A (en) * 1985-08-27 1988-05-24 Cellena (Cell Engineering) Ag Melatonin compositions and uses thereof
US4997845A (en) * 1987-02-02 1991-03-05 Eli Lilly And Company β-alkylmelatonins as ovulation inhibitors

Also Published As

Publication number Publication date
KR890700349A (ko) 1989-04-24
JPH1171276A (ja) 1999-03-16
HUT52954A (en) 1990-09-28
JPH02502724A (ja) 1990-08-30
FI894423A0 (fi) 1989-09-19
ZA882079B (en) 1988-09-15
PH26709A (en) 1992-09-15
EP0354921B1 (en) 1996-10-09
JP2965160B2 (ja) 1999-10-18
ATE143807T1 (de) 1996-10-15
AU8693891A (en) 1991-12-19
EG18583A (en) 1993-06-30
GR880100177A (el) 1989-01-31
FI894423A7 (fi) 1989-09-19
DD269557A5 (de) 1989-07-05
CN88101379A (zh) 1988-10-05
RU2114621C1 (ru) 1998-07-10
DE3855606D1 (de) 1996-11-14
ES2009251A6 (es) 1989-09-16
PT87053A (pt) 1989-03-30
CA1322527C (en) 1993-09-28
US4855305A (en) 1989-08-08
DE3855606T2 (de) 1997-02-13
IL85814A0 (en) 1990-02-09
AU5513494A (en) 1994-04-14
IN166946B (fa) 1990-08-11
OA09134A (en) 1991-10-31
HU208487B (en) 1993-11-29
GR1002146B (en) 1996-02-19
AU628784B2 (en) 1992-09-24
NZ223989A (en) 1991-08-27
EP0354921A1 (en) 1990-02-21
BR8807426A (pt) 1990-04-10
AU676523B2 (en) 1997-03-13
IL85814A (en) 1992-05-25
BG51075A1 (en) 1993-02-15
CN1041383C (zh) 1998-12-30
AU1683088A (en) 1988-11-02
WO1988007370A1 (en) 1988-10-06
EP0354921A4 (en) 1991-08-07
PT87053B (pt) 1993-09-30

Similar Documents

Publication Publication Date Title
FI894423L (fi) Kompositioner och foerfarande foer foerhindring av befruktning och kontroll av broestcancer.
FI870979L (fi) Filterkonstruktion och foerfarande foer bildande av filterkonstruktion.
FI87024B (fi) Foerfarande foer styrning av en kortsluten asynkronmotor och styrkrets.
FI871709A7 (fi) Foerfarande och anordning foer utraetning av gjutna anoder.
FI871274A0 (fi) Foerfarande och anordning foer styrning av bergborrning.
FI870287L (fi) Paelsdjursfoder och foerfarande foer framstaellning av detsamma.
FI872372A0 (fi) Foerfarande och anordning foer kapning av haolelement.
FI872303L (fi) Katalyt foer framstaellning av ataktiskt polypropen och foerfarande foer framstaellning av en dylik katalyt.
FI870184A0 (fi) Akustiskt stroemningsmaetningsfoerfarande och anordning foer tillaempning av detta.
FI871739A0 (fi) Foerfarande och anordning foer aotskiljning av vaetskor.
FI870747A7 (fi) Foerfarande och anordning foer foerbaettring av reglering och behandling av fibersuspensionsstroemning.
FI871730L (fi) Foerfarande foer framstaellning av hemicellulosahydrolysat och specialmassa.
FI872312A0 (fi) Foerfarande och anordning foer forskning av vaegbelaeggningars slitning.
FI871034A7 (fi) Foerfarande och anordning foer uppstapling av cellulosabalar.
FI80863B (fi) Foerfarande och anordning foer lagring av pappersrullar.
FI870339A0 (fi) Brottsensor och foerfarande foer framstaellning av densamma.
FI872141L (fi) Foerfarande och anordning foer montering av en innerskorsten.
FI871002A0 (fi) Foerfarande och anordning foer belaeggning av materialbana.
FI871167A0 (fi) Poroest saeckpapper och foerfarande foer tillverkning av detsamma.
FI871363A0 (fi) Foerfarande och anordning foer muddring av vattendrag.
FI870632A0 (fi) Traenings- och terapimedel och anvaendning av detta.
FI871241A0 (fi) Foerfarande foer framstaellning av vattentaet golvbelaeggning och vattentaet golvbelaeggning.
FI872320A0 (fi) Anordning foer underhaoll av vaegytor och motsvarande.
FI870943A0 (fi) Foerfarande foer framstaellning av raka kanaldelar och en kanaldel.
FI870878A0 (fi) Foerfarande och anordning foer begraensning av djurs roerelse.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: APPLIED MEDICAL RESEARCH, LTD.